Optimising antibiotic switching via forecasting of patient physiology
Magnus Ross, Nel Swanepoel, Akish Luintel, Emma McGuire, Ingemar J. Cox, Steve Harris, Vasileios Lampos, [1em] Department of Computer Science, Centre for AI, UCL, UK · 2026
Read Optimising antibiotic switching via forecasting of patient physiology by Magnus Ross, Nel Swanepoel, Akish Luintel, Emma McGuire, Ingemar J. Cox, Steve Harris, Vasileios Lampos, [1em] Department of Computer Science, Centre for AI, UCL, UK (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2603-08242.txt.
Introduction
Ross and colleagues forecast physiology to time intravenous-to-oral antibiotic switches. A switch shortens stays, cuts infections, and lowers costs, yet one in five English patients stay on intravenous drugs despite meeting switch criteria. Tools that learn from past choices repeat delays, so the team models vital sign trajectories with neural processes. It judges switch-readiness against guidelines, ranking patients. Outputs stay interpretable, adapt to guidelines without retraining, and leave judgment with clinicians. Tests on MIMIC-IV and UCLH pick more than twice as many patients as random choice.
Catalog record
| CREATOR | Magnus Ross, Nel Swanepoel, Akish Luintel, Emma McGuire, Ingemar J. Cox, Steve Harris, Vasileios Lampos, [1em] Department of Computer Science, Centre for AI, UCL, UK |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 78267 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2603.08242
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Optimising antibiotic switching via forecasting of patient physiology Magnus Ross, Nel Swanepoel, Akish Luintel, Emma McGuire, Ingemar J. Cox, Steve Harris, Vasileios Lampos, [1em] Department of Computer Science, Centre for AI, UCL, UK Abstract Timely transition from intravenous (IV) to oral antibiotic therapy shortens hospital stays, reduces catheter-related infections, and lowers healthcare costs, yet one in five patients in England remain on IV antibiotics despite meeting switching criteria. Clinical decision support systems can improve switching rates, but approaches that learn from historical decisions reproduce the delays and inconsistencies of routine practice. We propose using neural processes to model vital sign trajectories probabilistically, predicting switch-readiness by comparing forecasts against clinical guidelines rather than learning from past actions, and ranking patients to prioritise clinical review. The design yields interpretable outputs, adapts to updated guidelines without retraining, and preserves clinical judgement. Validated on MIMIC-IV (US intensive care, 6,333 encounters) and UCLH (a large urban academic UK hospital group, 10,584 encounters), the system selects 2.2–3.2 × \times more relevant patients than random. Our results demonstrate that forecasting patient physiology offers a principled foundation for decision support in antibiotic stewardship. 1 Introduction The timely transition of hospital patients from intravenous (IV) to oral antimicrobial therapy, known as the IV-to-oral switch (IVOS), benefits patients and hospitals [ 1 ] . Clinically, it can shorten hospital stays and reduce catheter-related bloodstream infections [ 2 , 3 ] ; operationally, it can free nursing time and reduce costs [ 4 ] . Yet IV therapy often continues after an oral alternative would be safe. In England, 19% of patients remain on IV antibiotics despite meeting switching criteria [ 5 ] , and some are not switched at all [ 6 ] . IVOS depends on timely review of a changing clinical picture, but that review is easy to miss on busy wards, especially when senior input or microbiology advice is delayed. IVOS decisions have two linked components [ 7 , 8 ] . The first is clinical stability : whether the patient is improving and likely to remain stable, assessed using trends in vital signs (e.g., temperature, heart rate, blood pressure, respiratory rate, oxygen saturation) and, where available, laboratory markers. The second is oral suitability : whether oral therapy is appropriate and feasible, for example that the patient can tolerate oral intake and that an appropriate oral agent is available. This paper targets clinical stability. Our task is to identify patients whose recent observations imply a high probability of staying within normal ranges in the near future, so they can be prioritised for review. This problem has a practical constraint [ 9 ] . In England, the median hospital has around 550 general/acute/maternity inpatients at any time, and about one third receive antibiotics. That volume exceeds the capacity of typical antimicrobial stewardship teams (infection specialists and specialist pharmacists). Decision support must therefore help them focus on the patients most likely to benefit from review. IVOS decisions also depend on information that is hard to capture reliably in structured EHR data (for example, surgical wound progress, source control plans, evolving imaging, or bedside assessments). The goal of a CDSS is therefore not to automate IVOS, but to surface patients for expert review and discussion with the primary team. Clinical decision support systems (CDSSs) can increase switching rates and reduce IV therapy days. Prior rule-based systems have reduced IV use through alerts based on fixed criteria [ 10 , 11 , 12 , 13 ] (see Supplementary S1 for a detailed review). However, fixed rules struggle to assess whether a patient is improving rather than merely meeting thresholds at one point in time. AI-enabled methods that learn from historical switching behaviour face a deeper limitation: if the training signal is what clinicians did , then the best the model can do is reproduce that sub-optimal behaviour. It cannot reliably improve practice against a clinical standard [ 14 , 15 ] . We propose an alternative approach that forecasts patient physiology rather than past clinical actions. Using neural processes to model vital sign trajectories probabilistically, we predict switch-readiness by applying clinical criteria to these forecasts. This avoids learning historical delays, side-steps the need to label switches from electronic health records (EHRs), and yields outputs clinicians can inspect directly (the forecast trajectories and their uncertainty). Because criteria are applied after forecasting, the system can be updated as clinical standards evolve without retraining the forecasting model, and it can be adapted in non-standard cases (e.g., discounting a variable that is clinically uninformative in context such as fever in patients on antipyretics). The system ranks patients by predicted switch-readiness, helping teams prioritise reviews while preserving clinical judgement for factors outside routine vital signs data. Figure 1 : The proposed AI-enabled IVOS system. A) Training a probabilistic neural process model to forecast patient trajectories. B) Using the trained model to generate likely trajectories over the following day and applying clinical criteria to determine the proportion of samples ready to be switched. C) Presentation of switch-readiness probabilities as a ranked list of patients for review. Figure 1 illustrates our system architecture. We forecast key vital signs ( A ), apply clinical criteria to estimate switch-readiness probabilities ( B ), and use these to rank patients for review ( C ). Oral suitability and the final IVOS decision remain with clinicians, who consider the broader clinical record and coordinate with the primary team after reviewing flagged patients [ 7 , 8 ] . Statistic MIMIC UCLH Number of admissions 6,333 10,584 Unique subjects 5,850 8,701 Age (years) 65.70 \pm 15.29 55.98 \pm 19.24 Length of stay (days) 17.69 \pm 17.07 14.23 \pm 14.42 Sex Female 2,579 (40.7%) 5,564 (52.6%) Male 3,754 (59.3%) 5,019 (47.4%) Top 5 Race/Ethnicity White: 3,772 (59.6%) White British: 3,324 (31.4%) Unknown: 1,074 (17.0%) Unknown: 3,033 (28.7%) Black: 720 (11.4%) Other White Bg.: 1,204 (11.4%) Other: 292 (4.6%) Other Ethnic Group: 671 (6.3%) Hispanic: 247 (3.9%) Black African: 509 (4.8%) Top 5 Oral Antibiotics Azithromycin: 724 (11.4%) Co-amoxiclav: 3,471 (32.8%) Metronidazole: 704 (11.1%) Clarithromycin: 797 (7.5%) Sulfameth/Trimeth: 477 (7.5%) Ciprofloxacin: 771 (7.3%) Doxycycline: 371 (5.9%) Amoxicillin: 421 (4.0%) Vancomycin: 370 (5.8%) Doxycycline: 410 (3.9%) Top 5 IV Antibiotics Vancomycin: 4,158 (65.7%) Co-amoxiclav: 4,920 (46.5%) Cefepime: 2,774 (43.8%) Pip.-Taz.: 3,841 (36.3%) Ceftriaxone: 2,629 (41.5%) Metronidazole: 2,849 (26.9%) Cefazolin: 2,249 (35.5%) Meropenem: 1,208 (11.4%) Metronidazole: 1,449 (22.9%) Ciprofloxacin: 882 (8.3%) Measurement variable Mean # per admission Mean # per admission Heart rate 157.8 81.1 Respiratory rate 154.0 78.4 SpO 2 154.9 80.8 Systolic BP 84.0 62.9 Temperature 36.1 61.9 Table 1 : Comparison of the evaluation set cohorts for MIMIC-IV and UCLH datasets. Categorical variables are reported as count (percentage of admissions). Continuous variables are reported as mean \pm standard deviation. MIMIC-IV records race while UCLH records ethnicity, reflecting the coding systems used in each source database; “Other White Bg” denotes Other White Background. Antibiotic frequencies may sum to more than 100% as patients can receive multiple antibiotics during an admission. The bottom section shows the mean number of vital sign measurements recorded per admission for each variable. Abbreviations: Pip.-Taz. (Piperacillin-Tazobactam), Sulfameth/Trimeth (Sulfamethoxazole-Trimethoprim), IV (Intravenous), SpO 2 (Oxygen Saturation), BP (Blood Pressure). 2 Results We validate our method using two distinct EHR datasets: MIMIC-IV v3.1 [